<DOC>
	<DOCNO>NCT01970566</DOCNO>
	<brief_summary>Obesity prevalent disorder link inflammation , insulin resistance , dyslipidemia , obstructive sleep apnea , atherosclerosis , associate significant morbidity mortality . This randomized clinical trial compare effectiveness Intense Exercise/Moderate Calorie Restriction ( IE-MCR ) , Topiramate-Phentermine ( TP ) cognitive behavioral therapy ( CBT ) obesity atherosclerosis individual morbidly obesity . This randomized clinical trial compare : 1 ) change fat mass atherosclerosis , 2 ) change psychological quality-of-life well economic burden response IE-MCR , TP CBT , 3 ) conduct exploratory mechanistic biomolecular , genetic therapeutic analysis develop intervention-specific individualized intervention model improve management morbidly obese individual .</brief_summary>
	<brief_title>Comparison Effect Intense-Exercise/Moderate-Calorie , Topiramate-Phentermine Cognitive Behavioral Therapy Obesity</brief_title>
	<detailed_description>Background . Obesity prevalent disorder ; 60 % US population associate significant morbidity mortality inflammation , insulin resistance , dyslipidemia , obstructive sleep apnea , atherosclerosis . The economic burden obesity-related illness substantial , estimate range 2 % 7 % total US health care expenditures billion dollar direct indirect cost society . This randomized clinical trial compare effectiveness Intense Exercise/Moderate Calorie Restriction ( IE-MCR ) , Topiramate-Phentermine ( TP ) cognitive behavioral therapy ( CBT ) obesity atherosclerosis morbidly obesity individual ( body mass index ( BMI ) &gt; 40 kg/m2 BMI &gt; 35 kg/m2 associate comorbidities ) diabetes mellitus ( DM ) . Importance/Significance . There cumulative increase rate obesity , 60 % US population . This randomized clinical trial compare : 1 ) change fat mass atherosclerosis , 2 ) change psychological status quality-of-life well economic burden response IE-MCR , TP CBT morbidly obese individual DM . Furthermore , 3 ) exploratory analyse evaluate different underling adipocyte molecular mechanism conduct . This investigate underlying genomic determinant characterizes management obesity compare biologic , clinical phenotype , cost effectiveness two intervention . These aim provide fundamental information ass beneficial effect within across intervention obesity atherosclerosis management help provide individualize intervention model improve management morbidly obese individual Method . A significant difference reduction fat mass , carotid/coronary atherosclerosis , improve psychological , quality life economic burden measure , well exploratory mechanism action across IE-MCR , TP CBT method , hypothesize . Over 5 year period , 60 morbidly obese individual diabetes mellitus age 18 old free clinical cardiovascular disease recruit Obesity Clinic Greater Los Angeles VA Health Care System , University California Los Angeles Captain Lovell Federal Healthcare Center . Eligible subject randomize either intense exercise/moderate calorie restriction , Topiramate-Phentermine cognitive behavioral therapy ( 20 group ) receive intervention 12-months . Intense exercise/moderate calorie restriction group receive lecture exercise general dietary measure include calorie counting . They prepare food , protein : carbohydrate : fat ratio 30:45:25 70 % rest daily energy expenditure ( RDEE ) , complete daily food exercise journal . They exercise ~2.5 hours/day , 1/4 supervise , year . Topiramate-Phentermine group receive full dose TP ( 15/92mg ) pill daily period 1-year . Furthermore , CBT group well IE-MCR TP receive weekly cognitive behavior therapy year . All subject undergo carotid ultrasound ; coronary compute tomography angiography , bioelectric impedance spectroscopy , dual-energy X-ray absorptiometry , ambulatory calorimetry , serial home rest metabolic rate serial home ( RMR ) , sleep apnea assessment abdominal fat pad fine-needle aspiration biopsy ( FNAB ) , well measurement oxidative stress/inflammatory/metabolic biomarkers baseline 1-year follow-up . Quality life , psychological health economic burden assess use standardized questionnaire . Participants complete quarterly trial visit physical exam , compliance intervention well ascertainment adverse effect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>Age 2070 year Competent give inform consent Obesity ( BMI &gt; 40 ) BMI &gt; 35 kg/m2 associate comorbidities Diabetes Mellitus Type II History coronary artery disease , myocardial infarction , coronary angioplasty bypass surgery Prior noncardiac illness estimate life expectancy &lt; 4 year Unable give inform consent Women pregnant lactate Prior bariatric surgery receive antiobesity drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Intense Exercise/Moderate Calorie Restriction</keyword>
	<keyword>Topiramate-Phentermine</keyword>
</DOC>